Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02168673 · ClinicalTrials.gov registry record
Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 1
- Enrollment target
NCT02168673 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 1 participants.
The verdict
NCT02168673 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
Cigarette smoking is the major risk factor for developing chronic obstructive pulmonary disease (COPD). Patients with COPD have difficulty clearing mucus and debris from their airways. Even smokers who have not developed COPD may have difficulty clearing the airways. This is partly because smoking impairs the function of cilia, tiny hairs lining the airways that sweep out mucus to keep the airways clean. The investigators have found that smoking reduces the length of cilia, which may contribute to the worsened cilia function in smoking and COPD. This is true even in smokers who show no signs of lung disease. The investigators believe that smoking affects levels of genes in lung cells, resulting in shorter cilia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-04 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02168673
The ClinicalTrials.gov registry entry for NCT02168673 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02168673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02168673 about?
NCT02168673 is a clinical study titled "Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke". Cigarette smoking is the major risk factor for developing chronic obstructive pulmonary disease (COPD). Patients with COPD have difficulty clearing mucus and debris from their airways. Even smokers who have not developed COPD may have difficulty clearing the airways. This is partly because smoking i...
What is the current status of trial NCT02168673?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2011-04. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT02168673?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.